Animal Health Market Trends

  • Report ID: 1225
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Animal Health Market Trends

Growth Drivers

  • Upsurge in Zoonotic Diseases - Zoonotic diseases, or zoonoses, are spurred by germs that transfer from animals to humans. These diseases are carried out by pathogenic micro-organisms such as bacteria, fungi, parasites, and viruses. These organisms cause a wide range of ailments in humans and animals, from minor ailments to severe illness and even death. Thus, zoonotic diseases are leading the growth of animal health market. According to the World Economic Forum, zoonotic diseases are expected to cause 60% of acknowledged communicable diseases and up to 75% of recently found or emerging infectious diseases.
  • Escalating Number of Livestock - For instance, in Europe, there were around 143 million pigs, 74 million cattle, 62 million sheep, and 10 million goats as of December 2021.
  • Growing Prevalence of Diabetes in Pets – It is observed in a research, the prevalence of diabetes in pets is on the rise, growing by almost 81% in dogs and 17% in cats over a ten-year span.
  • Growing Threat of Canine Parvovirus-2 (CPV-2) – For instance, in adult and young dogs, CPV-2 induces 100% morbidity and a 12% and 90% risk of mortality, accordingly.
  • Rise in Per Capita Income - As per the World Bank statistics, global annual per capita income increased by 4.8% in 2021 contrasted to 2019, while it only increased by 1.5% in that year.

Challenges

  • Stringent Government Policies on Approval of Animal Drugs
  • Price Hike in Animal Health Products
  • Escalating Cost of Animal Testing

Animal Health Market Highlights Over 2023 - 2033

Growth Drivers

  • Upsurge in Zoonotic Diseases - Zoonotic diseases, or zoonoses, are spurred by germs that transfer from animals to humans. These diseases are carried out by pathogenic micro-organisms such as bacteria, fungi, parasites, and viruses. These organisms cause a wide range of ailments in humans and animals, from minor ailments to severe illness and even death. Thus, zoonotic diseases are leading the growth of animal health market. According to the World Economic Forum, zoonotic diseases are expected to cause 60% of acknowledged communicable diseases and up to 75% of recently found or emerging infectious diseases.
  • Escalating Number of Livestock - For instance, in Europe, there were around 143 million pigs, 74 million cattle, 62 million sheep, and 10 million goats as of December 2021.
  • Growing Prevalence of Diabetes in Pets – It is observed in a research, the prevalence of diabetes in pets is on the rise, growing by almost 81% in dogs and 17% in cats over a ten-year span.
  • Growing Threat of Canine Parvovirus-2 (CPV-2) – For instance, in adult and young dogs, CPV-2 induces 100% morbidity and a 12% and 90% risk of mortality, accordingly.
  • Rise in Per Capita Income - As per the World Bank statistics, global annual per capita income increased by 4.8% in 2021 contrasted to 2019, while it only increased by 1.5% in that year.

Challenges

  • Stringent Government Policies on Approval of Animal Drugs
  • Price Hike in Animal Health Products
  • Escalating Cost of Animal Testing

The global animal health market is segmented and analyzed for demand and supply by product into pharmaceuticals, medicinal feed additives, and diagnostics. Out of these, the pharmaceuticals segment is estimated to garner the largest market share over the forecast period owing to the noticeable count of companion animals ownerships, growing number of veterinary practitioners, and surge in various zoonotic diseases across the globe. For instance, it estimated that, foot and mouth disease (FMD) affects nearly 76% of the world's cattle, primarily in Africa, the Middle East, and Asia, as well as a small portion of South America.

Base Year

2024

Forecast Year

2025-2037

CAGR

11.7%

Base Year Market Size (2024)

USD 48.36 billion

Forecast Year Market Size (2037)

USD 203.96 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 1225
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of animal health is evaluated at USD 52.93 billion.

The animal health market size was valued at USD 48.36 billion in 2024 and is expected to exceed USD 203.96 billion by the end of 2037, expanding at over 11.7% CAGR during the forecast period i.e., between 2025-2037. Upsurge in zoonotic diseases, escalating number of livestock, growing prevalence of diabetes in pets will impel the market growth.

North America industry is anticipated to hold largest revenue share by 2037, backed by increasing technological advancement, rise in research and development of more advanced therapeutics, growing number of pet adoption, and surge in zoonotic diseases in the region.

The major players in the market include Zoetis Inc., Heska Corporation, Merck & Co., Inc., Ceva Santé Animale, Virbac S.A., Midmark Corporation, Biogenesis Bago SA, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample